. . . . . . . "[Three markers, CDX2, VIL1 and BAI3, gave significantly different results in the two tumour types (P\uFFFD<\uFFFD0.0001): CDX2 and VIL1 in combination (either marker positive) showed sensitivity and specificity of 81% for LCNEC while BAI3 showed 89% sensitivity and 75% specificity for SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:49+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .